PTEN and neoplasm: Clonal analyses of tumour cells also show that ESRP1 gene amplification occurs step-wise in the development of aggressive early onset prostate cancer, following genetic changes in tumour-suppressor genes such as KLF5, BRCA1, RB1, PTEN and TP53 [14].